A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity (Q46945195)
Jump to navigation
Jump to search
scientific article published in October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity |
scientific article published in October 2007 |
Statements
1 reference
A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity (English)
1 reference
1 reference
David A Rider
1 reference
Carin E G Havenith
1 reference
Ruby de Ridder
1 reference
Janine Schuurman
1 reference
Cedric Favre
1 reference
Joanne C Cooper
1 reference
Simon Walker
1 reference
Ole Baadsgaard
1 reference
Susanne Marschner
1 reference
Jan G J vandeWinkel
1 reference
Denis R Alexander
1 reference
1 October 2007
1 reference
1 reference
67
1 reference
20
1 reference
9945-9953
1 reference